Several preclinical studies have proven the anti-inflammatory properties of apolipoproteins, such as apoA-I and apoA-IV, and decreased apolipoprotein levels in patients have been linked with immune diseases such as allergies [29,30] and chronic lung inflammation (reviewed in [31,32]). The gene discussed is APOA1; the disease is allergic disease.